18
views
0
recommends
+1 Recommend
3 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Telemedicine Services During COVID‐19: Considerations for Medically Underserved Populations

      article-commentary

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The recent outbreak of the novel Coronavirus (COVID‐19) has swept across the United States and is present in every US state and every major metropolitan area. As national, state, and local governments have begun implementing policies aimed at preventing the transmission and spread of COVID‐19, changes in health care delivery have inevitably emerged. During this extraordinary time, health care systems and providers are seeking alternative delivery methods to ensure their patients’ needs are met. Among the many approaches to continue providing needed care in the wake of physical distancing, telemedicine, defined as the use of technology to deliver clinical care remotely, remains a promising yet underutilized method. The purpose of this commentary is to explore the use of telemedicine in reaching underserved patients. Telemedicine and Medically Underserved Populations In response to COVID‐19, Medicare and Medicaid programs have begun expanding coverage and reimbursement of telemedicine services to promote care of beneficiaries using a variety of virtual communication methods. 1 Many private payers have made similar provisions. While definitions of the various telemedicine modalities are lacking in consistency, generally telehealth is defined as use of real‐time interactive audio and video in order to deliver care at a distance. Conversely, virtual visits are telephonic (audio only), and E‐visits make use of written communication, typically via an online patient portal. The basic technical requirements for telehealth are a broadband connection, an application for the video, technology support, and a device capable of handling the technology. 2 When functioning as designed, telemedicine offers a convenient and effective form of clinical care. 3 Unfortunately, if one or more of these components is missing, the entire system will not function and alternatives must be explored. In many cases, although health care organizations will pay the upfront costs for telehealth technology and make this available to their patients at no additional cost, a lack of broadband access for patients can effectively stymie full telehealth capabilities. 4 According to the Federal Communications Commission (FCC), there are approximately 24 million Americans who lack access to broadband, defined as Internet connections supporting sufficient download (25 megabits per second) and upload (3 megabits per second) speeds. 4 Nearly one‐third of Americans in rural areas lack broadband, and disparities are greater among people of lower socioeconomic status and people on tribal lands. 4 Older adults are also at a disadvantage: just 51% of Americans 65 and older have broadband at home, only 42% have a cellular phone, and even fewer have a “smart phone” capable of streaming video. 5 The patient population we serve at our clinic represents a microcosm of clinical panels across the United States. We serve a mixed rural‐suburban population, with a large concentration of patients who are older adults or have substance use disorder, low income, low levels of formal education, or who have some combination of all of these factors. The majority of patients we serve rely on insurance coverage through Medicare or Medicaid. For many of our patients, full access to telemedicine, particularly the video capabilities required of telehealth, is not feasible. A substantial proportion rely on landline telephone service, use prepaid cellular phones with limited data plans, use mobile carriers with narrow data coverage, or have limited broadband access, a problem exacerbated by high Internet usage due to, for instance, virtual schooling requirements for their children. We have encountered these challenges frequently when we contact our patients whose visits have been converted from in‐person to telemedicine, but then cannot launch the video for a telehealth platform or cannot take a phone call because they lack cellular reception during the time slotted for the visit. Our experience has been that even well‐resourced patients often run into issues with wireless coverage, making video connection a persistent challenge under seemingly ideal circumstances. Additional barriers unrelated to technological compatibility exist as well. For example, older patients are often less familiar and therefore less comfortable with video‐based technology. Cognitive and sensory impairments are also prevalent, and these barriers frustrate our ability to provide seamless care via video visit. 6 , 7 We find that many of these patients opt for a phone call or a home visit over pursuing telehealth when scheduling their appointments. Furthermore, our ability to perform remote monitoring which may otherwise guide clinical decision‐making for Medicare patients is limited. For example, Part B coverage of blood pressure monitoring devices remains confined to a limited subset of the population. Finally, some patients of any age group may experience a significant amount of stress at the prospect of a telehealth visit: one patient shared that she had spent all night cleaning her house before our care team could see into her private home. Given these challenges, and despite our best efforts, many of our remote visits, including those which are originally scheduled as video‐enabled telehealth visits, end up as audio‐only virtual visits. Until very recently, the clinical revenue generated by these audio‐only encounters was significantly less than would likely be required to maintain clinic solvency. Preliminary data from our practice suggest that reimbursement rates for telehealth mirror those of regular in‐office clinic visits, whereas telephone and patient‐initiated, asynchronous communications through an online portal known as E‐visits tend to reimburse at much lower rates, typically less than half that of full reimbursement. Nationally, Medicare reimbursement for telemedicine visits varies considerably (see Table 1). For telehealth visits, reimbursement rates from Centers for Medicare & Medicaid Services (CMS) range from approximately $46 for a 10‐minute visit to approximately $110 for a 25‐ to 30‐minute visit. 8 In contrast, for virtual visits and E‐visits, average rates have ranged from approximately $15 for a 5‐ to 10‐minute visit to approximately $41 for a 21‐ to 30‐minute visit. 8 Hence, telehealth visits yield more than twice the reimbursement for providers as compared to telephone calls or E‐visits of comparable duration. Table 1 Medicare Reimbursement for Telemedicine Visits Stratified by Encounter Type, April 2020 Description HCPCS Code Time National Nonfacility Rate NC Nonfacility Rate TelePHONE encounters (audio only) Virtual check‐in G2012 5‐10 min $14.80 Telephone E/M (physicians) 99441 5‐10 min $14.44 99442 11‐20 min $28.15 99443 21‐30 min $41.14 Telephone (nonphysicians) 98966 5‐10 min $14.44 98967 11‐20 min $28.15 98968 21‐30 min $41.14 E‐Visits (online using patient portal) Est Pt, online digital E/M (physicians) 99421 5‐10 min $15.52 99422 11‐20 min $31.04 99423 21‐30 min $50.16 Est Pt, online digital E/M (nonphysicians) G2061 5‐10 min $12.27 G2062 11‐20 min $21.65 G2063 21‐30 min $33.92 TeleHEALTH encounters (includes video) New Pt, outpatient E/M, Level 1 99201 10 min $46.56 $44.20 New Pt, outpatient E/M, Level 2 99202 20 min $77.23 $73.61 New Pt, outpatient E/M, Level 3 99203 30 min $109.35 $104.47 New Pt, outpatient E/M, Level 4 99204 45 min $167.09 $160.16 New Pt, outpatient E/M, Level 5 99205 60 min $211.12 $202.61 Est Pt, outpatient E/M, Level 2 99212 10 min $46.19 $43.86 Est Pt, outpatient E/M, Level 3 99213 15 min $76.15 $72.77 Est Pt, outpatient E/M, Level 4 99214 25 min $110.43 $105.81 Est Pt, outpatient E/M, Level 5 99215 40 min $148.33 $142.34 Initial annual wellness visit G0438 n/a $172.87 $166.10 Subsequent annual wellness visit G0439 n/a $117.29 $112.31 John Wiley & Sons, Ltd. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. Thankfully, some payers have announced their intent to address this discrepancy by raising the reimbursement rate for virtual visits. NC Medicaid, for example, has recognized the challenges that vulnerable populations and their providers encounter and, consequently, has updated its fee schedule for audio‐only encounters to allow enhanced reimbursement, albeit still lower than rates allowed for telehealth visits. 9 Unfortunately, certain types of encounters, such as Annual Wellness Visits for Medicare beneficiaries, are still required to be conducted via telehealth, eliminating our ability to continue providing these for many older adults. Discussion COVID‐19 is changing how we deliver health care. We are in an unprecedented time of intense learning and development. More medical practitioners than ever are providing care remotely, and similarly, more patients are seeking their care through remote methods. Although many patients will return to the clinic once the pandemic has subsided, it is likely that telemedicine will continue to play a prominent role, especially since: (1) telemedicine visits have frequently proven to be useful and convenient for patients and providers alike; (2) challenges related to the startup and sustainability of these services will have been overcome by many practices; and (3) we may see a resurgence of COVID‐19 and need to enact distancing measures again in the future. Although reimbursement appears to be on its way to aligning with patient needs, access barriers remain. To improve access to telemedicine, state‐level initiatives can aid with bridging gaps. Some states have made efforts to promote better access to broadband through a number of mechanisms, including direct funding through grant programs, income tax credits, and infrastructure coordination. 4 Unfortunately, not all states have these mechanisms in place and these efforts will not solve all telemedicine challenges—particularly for older patients who have cognitive or sensory impairments. Providers will continue to meet their patients’ needs to the best of their ability, during and after the pandemic. The use of telemedicine may be especially helpful in this endeavor for those who have transportation, distance, or mobility challenges. We have seen this for our rural patients who are enthusiastic about eliminating their considerable travel times and the costs associated with them. In order to ensure its success, particularly for patients who stand to reap the greatest benefit and the providers who serve them, policymakers will need to be aware of the possible unintended consequences of certain rules for medically underserved populations, and ensure that financial incentives are aligned with care needs and adequate resources are available.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: not found

          Prevalence of cognitive impairment without dementia in the United States.

          Cognitive impairment without dementia is associated with increased risk for disability, increased health care costs, and progression to dementia. There are no population-based prevalence estimates of this condition in the United States. To estimate the prevalence of cognitive impairment without dementia in the United States and determine longitudinal cognitive and mortality outcomes. Longitudinal study from July 2001 to March 2005. In-home assessment for cognitive impairment. Participants in ADAMS (Aging, Demographics, and Memory Study) who were age 71 years or older drawn from the nationally representative HRS (Health and Retirement Study). Of 1770 selected individuals, 856 completed initial assessment, and of 241 selected individuals, 180 completed 16- to 18-month follow-up assessment. Assessments, including neuropsychological testing, neurologic examination, and clinical and medical history, were used to assign a diagnosis of normal cognition, cognitive impairment without dementia, or dementia. National prevalence rates were estimated by using a population-weighted sample. In 2002, an estimated 5.4 million people (22.2%) in the United States age 71 years or older had cognitive impairment without dementia. Prominent subtypes included prodromal Alzheimer disease (8.2%) and cerebrovascular disease (5.7%). Among participants who completed follow-up assessments, 11.7% with cognitive impairment without dementia progressed to dementia annually, whereas those with subtypes of prodromal Alzheimer disease and stroke progressed at annual rates of 17% to 20%. The annual death rate was 8% among those with cognitive impairment without dementia and almost 15% among those with cognitive impairment due to medical conditions. Only 56% of the nondeceased target sample completed the initial assessment. Population sampling weights were derived to adjust for at least some of the potential bias due to nonresponse and attrition. Cognitive impairment without dementia is more prevalent in the United States than dementia, and its subtypes vary in prevalence and outcomes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Patient and clinician experiences with telehealth for patient follow-up care.

            The increasing and widespread availability of personal technology offers patients and clinicians the opportunity to utilize real-time virtual communication to enhance access to health services. Understanding the perceived value of different modes of care may help to shape the future use of technology.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community.

              To measure the prevalence of visual impairment in a large representative sample of people aged 75 years and over participating in the MRC trial of assessment and management of older people in the community. 53 practices in the MRC general practice research framework. Data were obtained from 14 600 participants aged 75 years and older. Prevalence of visual impairment overall (binocular visual acuity <6/18) which was categorised separately into low vision (binocular visual acuity <6/18-3/60) or blindness (binocular visual acuity of <3/60). The prevalence of binocular acuity <6/12 was presented for comparison with other studies. Visual acuity was measured using Glasgow acuity charts; glasses, if worn, were not removed. Visual acuity was available for 14 600 people out of 21 241 invited (69%). Among people with visual acuity data, 12.4% overall (1803) were visually impaired (95% confidence intervals 10.8% to 13.9%); 1501 (10.3%) were categorised as having low vision (8.7% to 11.8%), and 302 (2.1%) were blind (1.8% to 2.4%). At ages 75-79, 6.2% of the cohort were visually impaired (5.1% to 7.3%) with 36.9% at age 90+ (32.5% to 41.3%). At ages 75-79, 0.6% (0.4% to 0.8%) of the study population were blind, with 6.9% (4.8% to 9.0%) at age 90+. In multivariate regression, controlling for age, women had significant excess risk of visual impairment (odds ratio 1.43, 95% confidence interval 1.29 to 1.58). Overall, 19.9% of study participants had a binocular acuity of less than 6/12 (17.8% to 22.0%). The results from this large study show that visual impairment is common in the older population and that this risk increases rapidly with advancing age, especially for women. A relatively conservative measure of visual impairment was used. If visual impairment had been defined as visual acuity of <6/12 (American definition of visual impairment), the age specific prevalence estimates would have increased by 60%.
                Bookmark

                Author and article information

                Contributors
                casey_tak@unc.edu
                Journal
                J Rural Health
                J Rural Health
                10.1111/(ISSN)1748-0361
                JRH
                The Journal of Rural Health
                John Wiley and Sons Inc. (Hoboken )
                0890-765X
                1748-0361
                02 July 2020
                : 10.1111/jrh.12466
                Affiliations
                [ 1 ] Department of Family Medicine Mountain Area Health Education Center Asheville North Carolina
                [ 2 ] Division of Practice Advancement and Education, Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina
                [ 3 ] Department of Obstetrics and Gynecology Mountain Area Health Education Center Asheville North Carolina
                [ 4 ] Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina
                [ 5 ] UNC Health Sciences at Mountain Area Health Education Center Asheville North Carolina
                Author notes
                [*] [* ]For further information, contact: Casey R. Tak, PhD, Assistant Professor, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, CB#7355 Chapel Hill, NC 27599; e‐mail: casey_tak@ 123456unc.edu .

                Author information
                https://orcid.org/0000-0002-1203-1782
                Article
                JRH12466
                10.1111/jrh.12466
                7364549
                32613657
                c8f3f2f7-7e1b-4067-9d01-08e38b75e2e5
                © 2020 National Rural Health Association

                This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

                History
                Page count
                Figures: 0, Tables: 1, Pages: 4, Words: 1999
                Categories
                Commentary
                Commentary
                Custom metadata
                2.0
                corrected-proof
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.5 mode:remove_FC converted:15.07.2020

                access to care,health disparities,policy,primary care,telemedicine

                Comments

                Comment on this article